Avenir Wellness Solutions Inc (AVRW) Return on Equity ROE from the third quarter 2024 to third quarter 2023 and annually, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket
 


Avenir Wellness Solutions Inc   (AVRW)

Avenir Wellness Solutions Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Avenir Wellness Solutions Inc in the third quarter 2024?
Due to the lack of equity, it was not possible to calculate Avenir Wellness Solutions Inc 's return on equity (ROE) in its third quarter 2024

What is ROE?




Return On Equity (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -3 -4 -5 -8 -8
Return On Equity (TTM) - - - - -
AVRW's Total Ranking # # # # #
Equity (TTM) in Millions -13 -12 -11 -10 -10
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





AVRW Annual Return On Equity (Dec 31 2023)
2023




Total Equity in Millions -10 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -3 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AVRW's' Return on Equity at Yahoo Finance
AVRW's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AVRW's Competitors
Subscribers only: Roe for Avenir Wellness Solutions Inc 's Suppliers
Subscribers only: Return On Equity for AVRW's Customers




Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector ROE
Tg Therapeutics Inc   66.04 %
Abbvie Inc   65.52 %
Eli Lilly And Company  64.74 %
Mimedx Group Inc   63.54 %
Valion Bio Inc   57.15 %
Entera Bio Ltd   57.11 %
Idexx Laboratories Inc  55.42 %
Edwards Lifesciences Corporation  53.58 %
Medpace Holdings Inc   50.87 %
Siga Technologies Inc  49.06 %
Exelixis Inc   48.56 %
Zoetis Inc   48.19 %
Carlisle Companies Incorporated  47.30 %
Insulet Corporation  46.26 %
Waters Corporation  45.93 %
Lantheus Holdings Inc   43.11 %
Puma Biotechnology Inc   41.50 %
Pharmacyte Biotech Inc   40.98 %
Collegium Pharmaceutical Inc   40.81 %
Entrada Therapeutics Inc   38.93 %
Adma Biologics Inc   38.43 %
Exagen Inc   36.80 %
Kewaunee Scientific Corporation  35.42 %
Protagonist Therapeutics inc   34.68 %
Dexcom Inc   31.20 %
Merck and Co Inc   29.26 %
Prestige Consumer Healthcare Inc   29.04 %
Hims and Hers Health Inc   27.17 %
Engene Therapeutics Inc   26.95 %
Msa Safety Inc  26.74 %


Date modified: 2026-09-08T15:11:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.